US 12090139
Formulations comprising triptan compounds
granted A61KA61K31/40A61K31/404
Quick answer
US patent 12090139 (Formulations comprising triptan compounds) held by Tonix Medicines, Inc. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tonix Medicines, Inc.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/40, A61K31/404, A61K31/4045, A61K31/70